June 1 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LTD - REMESTEMCEL-L IMPROVES RESPIRATORY AND FUNCTIONAL OUTCOMES IN PATIENTS WITH INFLAMMATORY LUNG DISEASE
June 1 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LTD - REMESTEMCEL-L IMPROVES RESPIRATORY AND FUNCTIONAL OUTCOMES IN PATIENTS WITH INFLAMMATORY LUNG DISEASE